In 2019, highlighted studies discovered gut bacterial species associated with increased incidence of depression (93), and causal effects of butyrate-producing bacteria on metabolic traits confirmed by measuring glucose-stimulated insulin response and fecal short-chain fatty acids (94) and using bacterial species associated with obesity and poor lipidemia to improve cardiovascular risk models (89, 95). This evidence concerns the gene INS and major depressive disorder.